Cytokine And Hormone Immunotherapy

11th International Symposium
of Immunobiology
September 20-24, 2006
Granlibakken, Tahoe City, CA
Saturday September 23, 2006
9:00 am - 12:30 pm

CYTOKINE AND HORMONES IMMUNOTHERAPY
Chair: Myron Arlen, Peter Cohen
K+ and Ca2+ channels as targets for specific immunomodulation
George K. Chandy
Department of Physiology and Biophysics, University of California, Irvine, CA 92697

Gene expression impacts of interleukin-2 therapy
Francesco M. Marincola
Department of Transfusion Medicine, Clinical Center, Bethesda, MD 20892-1502

Treatment of Kaposi's sarcoma with IL-12
Robert Yarchoan
HIV and AIDS Malignancy Branch, CCR, NCI, National Institutes of Health, Bethesda, MD 20892-1868

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Andrew D. Weinberg
Department of Basic Immunology, The Earle A. Chiles Research Institute,
Providence Portland Medical Center, Portland, OR 97213, USA.

Panel Discussion
Site Info
©International Symposium on Immunobiology 2006.


	11th International Symposium of Immunobiology September 20-24, 2006 Granlibakken, Tahoe City, CA Saturday September 23, 2006 9:00 am - 12:30 pm CYTOKINE AND HORMONES IMMUNOTHERAPY Chair: Myron Arlen, Peter Cohen K+ and Ca2+ channels as targets for specific immunomodulation George K. Chandy Department of Physiology and Biophysics, University of California, Irvine, CA 92697 Gene expression impacts of interleukin-2 therapy Francesco M. Marincola Department of Transfusion Medicine, Clinical Center, Bethesda, MD 20892-1502 Treatment of Kaposi's sarcoma with IL-12 Robert Yarchoan HIV and AIDS Malignancy Branch, CCR, NCI, National Institutes of Health, Bethesda, MD 20892-1868 Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40 Andrew D. Weinberg Department of Basic Immunology, The Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213, USA. Panel Discussion